RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.720
+0.030 (1.78%)
At close: Sep 15, 2026, 4:00 PM EDT
1.736
+0.016 (0.93%)
After-hours: Sep 15, 2026, 4:17 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $77.62 million as of September 15, 2026. Its market cap has increased by 65.48% in one year.
Market Cap
77.62M
Enterprise Value
68.53M
1-Year Change
65.48%
Ranking
Category
Stock Price
$1.72
ChartMarket Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has increased from $68.64M to $77.62M, an increase of 13.08%. That is a compound annual growth rate of 2.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 77.62M | 152.11% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 79.78M |
| Verrica Pharmaceuticals | 78.60M |
| Acrivon Therapeutics | 78.42M |
| Kalaris Therapeutics | 77.96M |
| iBio, Inc. | 75.88M |
| Gain Therapeutics | 74.41M |
| Cingulate | 73.87M |
| NeurAxis | 71.58M |